NCT07607925
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07607925
Title A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Canton Ohio 44718 United States Details
GSK Investigational Site Toronto Ontario M5G 1X6 Canada Details
GSK Investigational Site Tokyo 135-8550 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field